Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

Urszula N Wasko^#^{1

2}, Jingjing Jiang^#³, Tanner C Dalton^{1

2}, Alvaro Curiel-Garcia^{1

2}, A Cole Edwards⁴, Yingyun Wang³, Bianca Lee³, Margo Orlen⁵, Sha Tian⁶, Clint A Stalnecker^{7

8}, Kristina Drizyte-Miller⁷, Marie Menard³, Julien Dilly^{9

10}, Stephen A Sastra^{1

2}, Carmine F Palermo^{1

2}, Marie C Hasselluhn^{1

2}, Amanda R Decker-Farrell^{1

2}, Stephanie Chang³, Lingyan Jiang³, Xing Wei³, Yu C Yang³, Ciara Helland³, Haley Courtney³, Yevgeniy Gindin³, Karl Muonio³, Ruiping Zhao³, Samantha B Kemp⁵, Cynthia Clendenin¹¹, Rina Sor¹¹, William P Vostrejs⁵, Priya S Hibshman⁴, Amber M Amparo⁷, Connor Hennessey^{9

10}, Matthew G Rees¹², Melissa M Ronan¹², Jennifer A Roth¹², Jens Brodbeck³, Lorenzo Tomassoni^{2

13}, Basil Bakir^{1

2}, Nicholas D Socci¹⁴, Laura E Herring¹⁵, Natalie K Barker¹⁵, Junning Wang^{9

10}, James M Cleary^{9

10}, Brian M Wolpin^{9

10}, John A Chabot¹⁶, Michael D Kluger¹⁶, Gulam A Manji^{1

2}, Kenneth Y Tsai^{17

18}, Miroslav Sekulic¹⁹, Stephen M Lagana¹⁹, Andrea Califano^{1

2

13

20

21

22

23

24}, Elsa Quintana³, Zhengping Wang³, Jacqueline A M Smith³, Matthew Holderfield³, David Wildes³, Scott W Lowe^{6

25}, Michael A Badgley^{1

2}, Andrew J Aguirre^{9

10

12

26}, Robert H Vonderheide^{5

11

27}, Ben Z Stanger^{5

11}, Timour Baslan²⁸, Channing J Der^{7

8}, Mallika Singh²⁹, Kenneth P Olive^{30

31}

Affiliations

¹ Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
² Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
³ Revolution Medicines, Redwood City, CA, USA.
⁴ Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
⁵ University of Pennsylvania Perelman School of Medicine, Department of Medicine, Philadelphia, PA, USA.
⁶ Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁷ Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
⁸ Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
⁹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
¹⁰ Harvard Medical School, Boston, MA, USA.
¹¹ University of Pennsylvania Perelman School of Medicine, Abramson Cancer Center, Philadelphia, PA, USA.
¹² The Broad Institute of Harvard and MIT, Cambridge, MA, USA.
¹³ Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA.
¹⁴ Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
¹⁵ UNC Michael Hooker Proteomics Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
¹⁶ Department of Surgery, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
¹⁷ Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
¹⁸ Department of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
¹⁹ Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USA.
²⁰ Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
²¹ J. P. Sulzberger Columbia Genome Center, Columbia University, New York, NY, USA.
²² Department of Biochemistry and Molecular Biophysics, Columbia University Irving Medical Center, New York, NY, USA.
²³ Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.
²⁴ Chan Zuckerberg Biohub New York, New York, NY, USA.
²⁵ Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
²⁶ Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
²⁷ Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.
²⁸ Department of Biomedical Sciences, School of Veterinary Medicine, The University of Pennsylvania, Philadelphia, PA, USA.
²⁹ Revolution Medicines, Redwood City, CA, USA. msingh@revmed.com.
³⁰ Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA. kenolive@columbia.edu.
³¹ Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA. kenolive@columbia.edu.

^# Contributed equally.

PMID: 39533066
PMCID: PMC11602731
DOI: 10.1038/s41586-024-08084-7

Published Erratum

Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

Urszula N Wasko et al. Nature. 2024 Nov.

. 2024 Nov;635(8040):E12.

doi: 10.1038/s41586-024-08084-7.

Authors

Affiliations

¹ Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
² Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
³ Revolution Medicines, Redwood City, CA, USA.
⁴ Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
⁵ University of Pennsylvania Perelman School of Medicine, Department of Medicine, Philadelphia, PA, USA.
⁶ Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁷ Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
⁸ Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
⁹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
¹⁰ Harvard Medical School, Boston, MA, USA.
¹¹ University of Pennsylvania Perelman School of Medicine, Abramson Cancer Center, Philadelphia, PA, USA.
¹² The Broad Institute of Harvard and MIT, Cambridge, MA, USA.
¹³ Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA.
¹⁴ Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
¹⁵ UNC Michael Hooker Proteomics Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
¹⁶ Department of Surgery, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
¹⁷ Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
¹⁸ Department of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
¹⁹ Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USA.
²⁰ Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
²¹ J. P. Sulzberger Columbia Genome Center, Columbia University, New York, NY, USA.
²² Department of Biochemistry and Molecular Biophysics, Columbia University Irving Medical Center, New York, NY, USA.
²³ Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.
²⁴ Chan Zuckerberg Biohub New York, New York, NY, USA.
²⁵ Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
²⁶ Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
²⁷ Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.
²⁸ Department of Biomedical Sciences, School of Veterinary Medicine, The University of Pennsylvania, Philadelphia, PA, USA.
²⁹ Revolution Medicines, Redwood City, CA, USA. msingh@revmed.com.
³⁰ Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA. kenolive@columbia.edu.
³¹ Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA. kenolive@columbia.edu.

^# Contributed equally.

PMID: 39533066
PMCID: PMC11602731
DOI: 10.1038/s41586-024-08084-7

No abstract available

PubMed Disclaimer

Erratum for

Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer.
Wasko UN, Jiang J, Dalton TC, Curiel-Garcia A, Edwards AC, Wang Y, Lee B, Orlen M, Tian S, Stalnecker CA, Drizyte-Miller K, Menard M, Dilly J, Sastra SA, Palermo CF, Hasselluhn MC, Decker-Farrell AR, Chang S, Jiang L, Wei X, Yang YC, Helland C, Courtney H, Gindin Y, Muonio K, Zhao R, Kemp SB, Clendenin C, Sor R, Vostrejs WP, Hibshman PS, Amparo AM, Hennessey C, Rees MG, Ronan MM, Roth JA, Brodbeck J, Tomassoni L, Bakir B, Socci ND, Herring LE, Barker NK, Wang J, Cleary JM, Wolpin BM, Chabot JA, Kluger MD, Manji GA, Tsai KY, Sekulic M, Lagana SM, Califano A, Quintana E, Wang Z, Smith JAM, Holderfield M, Wildes D, Lowe SW, Badgley MA, Aguirre AJ, Vonderheide RH, Stanger BZ, Baslan T, Der CJ, Singh M, Olive KP. Wasko UN, et al. Nature. 2024 May;629(8013):927-936. doi: 10.1038/s41586-024-07379-z. Epub 2024 Apr 8. Nature. 2024. PMID: 38588697 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- PubMed Central
Molecular Biology Databases
- NIAID Data Ecosystem - Find datasets on Infectious and Immune-mediated Diseases

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

Affiliations

Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Molecular Biology Databases